IVBXF
PINK Innovent Biologics, Inc.$13.36 ↑ +0.91 (+7.27%) Trading Up from the previous close of $12.45, and at the day’s high of $13.36
- YTD change
- +37.03%
- vs 20-day SMA
- +3.71%
- vs 200-day SMA
- +17.26%
Price ranges
Price & Performance
+3.36 (+33.60%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 11.0% away from all-time highs of $15.01
- IVBXF is up 37% since the beginning of the year
- IVBXF is up 10% over the past 12 months
- IVBXF is up 8% over the past 1 month
- 0% of all IVBXF investors are betting against IVBXF
IVBXF reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +9.1%.
- Previous minute
- +$0.00
- Last hour
- +$0.00
- Last 5 days
- +21.39%
- vs 8-day SMA
- +7.69%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Innovent Biologics, Inc. is a biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases. It operates through the following geographical segments: The People's Republic of China (PRC), the United States of America (USA), and Indonesia. The company was founded by De Chao Yu, Kevin Chen, and Scott M. Wheelwright on April 28, 2011 and is headquartered in Suzhou, China.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
